Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC)
Clinical trial NCT03499626 · UNKNOWN
Trial details
- NCT number
- NCT03499626
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-05
- Primary completion
- 2019-05-05
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.